argenx SE | ARGX - SCHULD





SCHULD Veränderung Datum
AstraZeneca USD 33.92B 4.3B 2026-03
Genmab DKK 148M 5M 2025-06
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
GRIFOLS EUR 9.57B 746.56M 2025-12
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Qiagen NV USD 1.65B 165.82M 2026-03
UCB EUR 3.03B 12M 2024-12